{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:22:38Z","timestamp":1792689758189,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Paget\u2019s disease of bone (PDB) is a chronic, focal metabolic bone disorder characterized by increased bone destruction and disordered bone formation, and is a rare disease in Asian populations. This review aims to systematically summarize the pathogenesis, ocular manifestations, and treatment strategies for PDB, with the goal of enhancing the understanding of its multi-system involvement and exploring more effective clinical management approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of electronic databases, including PubMed, was conducted using Boolean operators to combine keywords such as \u201cPaget\u2019s disease of bone\u201d, \u201costeitis deformans\u201d, \u201cpathogenesis\u201d, \u201cdisease mechanism\u201d, \u201cocular\u201d, \u201coculus\u201d, \u201cophthalmic\u201d, \u201ceye\u201d, \u201ctreatment\u201d, \u201cpharmacotherapy\u201d, \u201cmedication\u201d, etc. Following an initial screening and the exclusion of duplicate records, relevant articles were selected for comprehensive analysis. The level of evidence was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>68 articles were included. This review elaborates on the roles of genetic and environmental factors in PDB and details its diverse ocular manifestations, including ptosis, cataract, macular disease, angioid streaks, optic neuropathy, and orbital disease. It also summarizes advances in current pharmacotherapy, primarily based on bisphosphonates, and other potential treatment strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Abnormal bone remodeling, driven by a combination of genetic susceptibility and environmental factors, constitutes the common pathological basis for both systemic skeletal lesions and specific ocular complications in PDB. Management should be based on multidisciplinary collaboration, integrating pharmacological intervention with individualized ocular care to control disease progression and prevent visual impairment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04412-4","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T10:34:57Z","timestamp":1780137297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Paget\u2019s disease of bone: pathogenesis, ocular manifestations, and therapeutic strategies"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6136-9894","authenticated-orcid":false,"given":"Bei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"4412_CR1","doi-asserted-by":"crossref","unstructured":"Paget J. On a form of chronic inflammation of bones (Osteitis Deformans). Med Chir Trans. 1877;60:37\u201364.9.","DOI":"10.1177\/095952877706000105"},{"issue":"3","key":"4412_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.5603\/ep.102636","volume":"76","author":"K Wandzilak","year":"2025","unstructured":"Wandzilak K, Renke M, Obo\u0142o\u0144czyk \u0141. Surprising diagnosis of Paget\u2019s disease of bone during malignancy diagnosis. Endokrynol Pol. 2025;76(3):347\u20138.","journal-title":"Endokrynol Pol"},{"issue":"6","key":"4412_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.7861\/clinmed.20.6.page","volume":"20","author":"SP Tuck","year":"2020","unstructured":"Tuck SP, Walker J. Adult Paget\u2019s disease of bone. Clin Med (Lond). 2020;20(6):568\u201371.","journal-title":"Clin Med (Lond)"},{"key":"4412_CR4","doi-asserted-by":"publisher","first-page":"932065","DOI":"10.3389\/fcell.2022.932065","volume":"10","author":"L Gennari","year":"2022","unstructured":"Gennari L, Rendina D, Merlotti D, Cavati G, Mingiano C, Cosso R, Materozzi M, Pirrotta F, Abate V, Calabrese M, Falchetti A. Update on the pathogenesis and genetics of Paget\u2019s disease of bone. Front Cell Dev Biol. 2022;10:932065.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"4412_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1127\/0003-5548\/2012\/0224","volume":"69","author":"A Morales-Piga","year":"2012","unstructured":"Morales-Piga A, Bachiller-Corral J, Villaverde-Hueso A, Alonso-Ferreira V, Posada de la Paz M, L\u00f3pez-Abente G. Further evidence supporting a genetic background for Paget\u2019s disease of bone in Spain. Anthropol Anz. 2012;69(4):417\u201322.","journal-title":"Anthropol Anz"},{"issue":"8","key":"4412_CR6","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1080\/07391102.2020.1758212","volume":"39","author":"NA Shaik","year":"2021","unstructured":"Shaik NA, Nasser KK, Alruwaili MM, Alallasi SR, Elango R, Banaganapalli B. Molecular modelling and dynamic simulations of sequestosome 1 (SQSTM1) missense mutations linked to Paget disease of bone. J Biomol Struct Dyn. 2021;39(8):2873\u201384.","journal-title":"J Biomol Struct Dyn"},{"key":"4412_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuroscience.2025.07.011","volume":"581","author":"N Singh","year":"2025","unstructured":"Singh N, Mishra D, Gomes J. Deleterious Sequestosome 1 mutations G262R and P438L in amyotrophic lateral sclerosis cause autophagy and oxidative stress imbalance. Neuroscience. 2025;581:233\u201346.","journal-title":"Neuroscience"},{"key":"4412_CR8","doi-asserted-by":"publisher","first-page":"116258","DOI":"10.1016\/j.biopha.2024.116258","volume":"172","author":"J Jin","year":"2024","unstructured":"Jin J, Huang R, Chang Y, Yi X. Roles and mechanisms of optineurin in bone metabolism. Biomed Pharmacother. 2024;172:116258.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4412_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41418-019-0341-6","volume":"27","author":"SW Wong","year":"2020","unstructured":"Wong SW, Huang BW, Hu X, Ho Kim E, Kolb JP, Padilla RJ, Xue P, Wang L, Oguin TH 3rd, Miguez PA, Tseng HC, Ko CC, Martinez J. Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget\u2019s disease. Cell Death Differ. 2020;27(1):71\u201384.","journal-title":"Cell Death Differ"},{"issue":"4","key":"4412_CR10","doi-asserted-by":"publisher","first-page":"eade6998","DOI":"10.1126\/sciadv.ade6998","volume":"9","author":"X Hu","year":"2023","unstructured":"Hu X, Wong SW, Liang K, Wu TH, Wang S, Wang L, Liu J, Yamauchi M, Foster BL, Ting JP, Zhao B, Tseng HC, Ko CC. Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget\u2019s disease of bone. Sci Adv. 2023;9(4):eade6998.","journal-title":"Sci Adv"},{"issue":"9","key":"4412_CR11","doi-asserted-by":"publisher","first-page":"e0310157","DOI":"10.1371\/journal.pone.0310157","volume":"19","author":"YM Chung","year":"2024","unstructured":"Chung YM, Hu CS, Sun E, Tseng HC. Morphological multiparameter filtration and persistent homology in mitochondrial image analysis. PLoS ONE. 2024;19(9):e0310157.","journal-title":"PLoS ONE"},{"issue":"1","key":"4412_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13023-025-03804-2","volume":"20","author":"J Horackova","year":"2025","unstructured":"Horackova J, Taslerova R, Bayer M, Nekvindova J, Pavlikova L, Horacek JM, Palicka V. Juvenile Paget disease with unique compound heterozygous sequence variants in the TNFRSF11B gene. Orphanet J Rare Dis. 2025;20(1):409.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"4412_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11914-021-00676-w","volume":"19","author":"NS Makaram","year":"2021","unstructured":"Makaram NS, Ralston SH. Genetic Determinants of Paget\u2019s Disease of Bone. Curr Osteoporos Rep. 2021;19(3):327\u201337.","journal-title":"Curr Osteoporos Rep"},{"key":"4412_CR14","doi-asserted-by":"publisher","first-page":"115364","DOI":"10.1016\/j.bone.2020.115364","volume":"137","author":"MP Whyte","year":"2020","unstructured":"Whyte MP, Campeau PM, McAlister WH, Roodman GD, Kurihara N, Nenninger A, Duan S, Gottesman GS, Bijanki VN, Sedighi H, Veis DJ, Mumm S. Juvenile Paget\u2019s Disease from Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7). Bone. 2020;137:115364.","journal-title":"Bone"},{"issue":"3","key":"4412_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/genes14030676","volume":"14","author":"RCA Columbres","year":"2023","unstructured":"Columbres RCA, Chin Y, Pratti S, Quinn C, Gonzalez-Cuyar LF, Weiss M, Quintero-Rivera F, Kimonis V. Novel Variants in the VCP Gene Causing Multisystem Proteinopathy 1. Genes (Basel). 2023;14(3):676.","journal-title":"Genes (Basel)"},{"issue":"24","key":"4412_CR16","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1093\/hmg\/ddaa248","volume":"29","author":"L Weiss","year":"2021","unstructured":"Weiss L, Jung KM, Nalbandian A, Llewellyn K, Yu H, Ta L, Chang I, Migliore M, Squire E, Ahmed F, Piomelli D, Kimonis V. Ceramide contributesto pathogenesis and may be targeted for therapy in VCP inclusion body myopathy. Hum Mol Genet. 2021;29(24):3945\u201353.","journal-title":"Hum Mol Genet"},{"key":"4412_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.05.031","volume":"489","author":"F di Scotto","year":"2020","unstructured":"di Scotto F, Whyte MP, Gianfrancesco F. The two faces of giant cell tumor of bone. Cancer Lett. 2020;489:1\u20138.","journal-title":"Cancer Lett"},{"issue":"5","key":"4412_CR18","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3803\/EnM.2022.1575","volume":"37","author":"YJ Choi","year":"2022","unstructured":"Choi YJ, Sohn YB, Chung YS. Updates on Paget\u2019s Disease of Bone. Endocrinol Metab (Seoul). 2022;37(5):732\u201343.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"4412_CR19","doi-asserted-by":"publisher","first-page":"850462","DOI":"10.3389\/fendo.2022.850462","volume":"13","author":"X Tao","year":"2022","unstructured":"Tao X, Liu L, Yang X, Wei Z, Chen Z, Zhang G, Zhang Z, Yue H. Clinical Characteristics and Pathogenic Gene Identification in Chinese Patients with Paget\u2019s Disease of Bone. Front Endocrinol (Lausanne). 2022;13:850462.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"4412_CR20","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1093\/rheumatology\/keaf280","volume":"64","author":"C Rebollo-Najera","year":"2025","unstructured":"Rebollo-Najera C, Usategui-Mart\u00edn R, Lobato-Carrasco J, Dom\u00ednguez-Gil-Gonz\u00e1lez M, Mir\u00f3n-Canelo JA, Miramontes-Gonz\u00e1lez P, Ralston SH, Corral-Gudino L. Continuous decline in Paget\u2019s disease of bone: a One Health perspective on 2342 new diagnoses and their association with rural livestock. Rheumatology (Oxford). 2025;64(9):5081\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"4412_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00223-019-00578-1","volume":"105","author":"D Rendina","year":"2019","unstructured":"Rendina D, De Filippo G, Merlotti D, Di Stefano M, Succoio M, Muggianu SM, Bianciardi S, D\u2019Elia L, Coppo E, Faraonio R, Nuti R, Strazzullo P, Gennari L. Vitamin D Status in Paget Disease of Bone and Efficacy-Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D. Calcif Tissue Int. 2019;105(4):412\u201322.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"4412_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jbspin.2018.12.007","volume":"86","author":"MS Numan","year":"2019","unstructured":"Numan MS, Jean S, Dessay M, Gagnon E, Amiable N, Brown JP. MichouL. Gene-environment interactions in Paget\u2019s disease of bone. Joint Bone Spine. 2019;86(3):373\u201380.","journal-title":"Joint Bone Spine"},{"issue":"2","key":"4412_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00223-024-01241-0","volume":"115","author":"T Cundy","year":"2024","unstructured":"Cundy T. The Decline of Paget\u2019s Disease of Bone and Domestic Coal Use-A Hypothesis. Calcif Tissue Int. 2024;115(2):117\u201323.","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"4412_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00223-017-0265-4","volume":"101","author":"MR Visconti","year":"2017","unstructured":"Visconti MR, Usategui-Mart\u00edn R, Ralston SH. Antibody Response to Paramyxoviruses in Paget\u2019s Disease of Bone. Calcif Tissue Int. 2017;101(2):141\u20137.","journal-title":"Calcif Tissue Int"},{"key":"4412_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3329\/bmrcb.v50i2.75574","volume":"50","author":"Kaisar","year":"2024","unstructured":"Kaisar, Haroon. Md. Shafiul Alam, Md. Nowfel Islam.Giant Cell Tumour in a Patient with Paget\u2019s Disease of the Skull Bone - A Rare Case Report. Bangladesh Med Res Counc Bull. 2024;50:111\u20135.","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"4412_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/bjo.74.10.579","volume":"74","author":"TR Dabbs","year":"1990","unstructured":"Dabbs TR, Skjodt K. Prevalence of angioid streaks and other ocular complications of paget\u2019s disease of bone. Br J Ophthalmol. 1990;74:579\u201382.","journal-title":"Br J Ophthalmol"},{"key":"4412_CR27","doi-asserted-by":"crossref","unstructured":"Fasana R, Eriksen NS, Borrelli E, Pfau K, Subhi Y. Intravitreal faricimab treatment for traumatic choroidal rupture and macular neovascularization in angioid streaks: a case report. Eur J Ophthalmol. 2025 Dec;24:11206721251395518.","DOI":"10.1177\/11206721251395518"},{"issue":"8","key":"4412_CR28","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s41433-022-02189-x","volume":"37","author":"JB Nadelmann","year":"2023","unstructured":"Nadelmann JB, Li Y, McGeehan B, Yu Y, VanderBeek BL. Systemic disease associations with angioid streaks in a large healthcare claims database. Eye (Lond). 2023;37(8):1596\u2013601.","journal-title":"Eye (Lond)"},{"issue":"6","key":"4412_CR29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/archophthalmol.2010.76","volume":"128","author":"NM Kerr","year":"2010","unstructured":"Kerr NM, Cassinelli HR, DiMeglio LA, Tau C, T\u00fcys\u00fcz B, Cundy T, Vincent AL. Ocular manifestations of juvenile Paget disease. Arch Ophthalmol. 2010;128(6):698\u2013703.","journal-title":"Arch Ophthalmol"},{"key":"4412_CR30","unstructured":"Tripathy K, Quint JM. Angioid streaks. 2024 Mar 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan."},{"issue":"4","key":"4412_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0002-9394(14)76136-7","volume":"97","author":"P Eretto","year":"1984","unstructured":"Eretto P, Krohel GB, Shihab ZM, Wallach S, Hay P. Optic neuropathy in Paget\u2019s disease. Am J Ophthalmol. 1984;97(4):505\u201310.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"4412_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/rheumatology\/41.8.948","volume":"41","author":"C Isasi","year":"2002","unstructured":"Isasi C, Sanz J, Hij\u00f3s M, Vaquero M, Saucedo G, Andreu JL. Successful treatment of optic neuropathy in osteitis deformans. Rheumatology (Oxford). 2002;41(8):948\u201350.","journal-title":"Rheumatology (Oxford)"},{"key":"4412_CR33","doi-asserted-by":"crossref","unstructured":"Yuan M, Chiou CA, Hu JCW, Zekavat SM, Eliott D, Patel AB, Lefebvre DR. Orbital and ocular venous congestion: a rare manifestation of hypervascular paget disease of the bone. Ophthalmic Plast Reconstr Surg. 2025 Sep-Oct 01;41(5): e154\u20137.","DOI":"10.1097\/IOP.0000000000002909"},{"issue":"Pt 4","key":"4412_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/eye.1994.116","volume":"8","author":"S Kheterpal","year":"1994","unstructured":"Kheterpal S, Downes SM, Eagling EM. Paget\u2019s disease presenting with exophthalmos. Eye (Lond). 1994;8(Pt 4):480\u20131.","journal-title":"Eye (Lond)"},{"issue":"5","key":"4412_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/00002341-200209000-00014","volume":"18","author":"TG Hardy","year":"2002","unstructured":"Hardy TG, McNab AA. Bilateral enophthalmos associated with paget disease of the skull: a case report. Ophthalmic Plast Reconstr Surg. 2002;18(5):388\u201390.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"4412_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/01676830.2010.485717","volume":"29","author":"AS Tari","year":"2010","unstructured":"Tari AS, Fard MA. Solitary orbital paget disease: a case report. Orbit. 2010;29(4):219\u201321.","journal-title":"Orbit"},{"issue":"9","key":"4412_CR37","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/jjco\/hyaf086","volume":"55","author":"K Ogura","year":"2025","unstructured":"Ogura K, Morizane C, Satake T, Iwata S, Toda Y, Muramatsu S, Takemori T, Kondo H, Kobayashi E, Arakawa A, Ogawa C, Katoh Y, Higashi T, Kawai A. Incidence and age- and site-specific characteristics of osteosarcoma: a population-based study using National Cancer Registry 2016\u20132019. Jpn J Clin Oncol. 2025;55(9):1037\u201345.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"4412_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00002341-199801000-00013","volume":"14","author":"KD Epley","year":"1998","unstructured":"Epley KD, Lasky JB, Karesh JW. Osteosarcoma of the orbit associated with Paget disease. Ophthalmic Plast Reconstr Surg. 1998;14(1):62\u20136.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"8","key":"4412_CR39","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/S0161-6420(00)00180-9","volume":"107","author":"S Goldberg","year":"2000","unstructured":"Goldberg S, Slamovits TL, Dorfman HD, Rosenbaum PS. Sarcomatous transformation of the orbit in a patient with Paget\u2019s disease. Ophthalmology. 2000;107(8):1464\u20137.","journal-title":"Ophthalmology"},{"issue":"2","key":"4412_CR40","first-page":"141","volume":"3","author":"H Farhangi","year":"2015","unstructured":"Farhangi H, Farzadnia M, Alamdaran A. Childhood Facial Osteo Sarcoma: a Case Report. Arch Bone Jt Surg. 2015;3(2):141\u20133.","journal-title":"Arch Bone Jt Surg"},{"issue":"2","key":"4412_CR41","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s12020-024-03791-7","volume":"85","author":"I Ayalon-Dangur","year":"2024","unstructured":"Ayalon-Dangur I, Rudman Y, Tsvetov G, Slutzky-Shraga I, Akirov A, Shimon I, Hirsch D, Gorshtein A. Long-term effectiveness of zoledronic acid in patients with Paget\u2019s disease of bone - a retrospective cohort study. Endocrine. 2024;85(2):873\u201382.","journal-title":"Endocrine"},{"key":"4412_CR42","doi-asserted-by":"publisher","first-page":"100762","DOI":"10.1016\/j.bonr.2021.100762","volume":"14","author":"J H\u00f6ppner","year":"2021","unstructured":"H\u00f6ppner J, Steff K, Misof BM, Sch\u00fcndeln MM, H\u00f6vel M, L\u00fccke T, Grasemann C. Clinical course in two children with Juvenile Paget\u2019s disease duringlong-term treatment with intravenous bisphosphonates. Bone Rep. 2021;14:100762.","journal-title":"Bone Rep"},{"issue":"4","key":"4412_CR43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/jbmr.3029","volume":"32","author":"T Cundy","year":"2017","unstructured":"Cundy T, Maslowski K, Grey A, Reid IR. Durability of Response to Zoledronate Treatment and Competing Mortality in Paget\u2019s Disease of Bone. J Bone Min Res. 2017;32(4):753\u20136.","journal-title":"J Bone Min Res"},{"issue":"6","key":"4412_CR44","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s40618-024-02318-1","volume":"47","author":"D Rendina","year":"2024","unstructured":"Rendina D, Falchetti A, Diacinti D, Bertoldo F, Merlotti D, Giannini S, Cianferotti L, Girasole G, Di Monaco M, Gonnelli S, Malavolta N, Minisola S, Vescini F, Rossini M, Frediani B, Chiodini I, Asciutti F, Gennari L. Diagnosis and treatment of Paget\u2019s disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS). J Endocrinol Invest. 2024;47(6):1335\u201360.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"4412_CR45","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/ard-2023-224990","volume":"83","author":"J Phillips","year":"2024","unstructured":"Phillips J, Subedi D, Lewis SC, Keerie C, Cronin O, Porteous M, Moore D, Cetnarskyj R, Ranganath L, Selby PL, Turgut T, Hampson G, Chandra R, Ho S, Tobias J, Young-Min S, McKenna MJ, Crowley RK, Fraser WD, Tang JCY, Gennari L, Nuti R, Brandi ML, Del Pino-Montes J, Devogelaer JP, Durnez A, Isaia GC, Di Stefano M, Guanabens N, Blanch Rubio J, Seibel MJ, Walsh JP, Rea SL, Kotowicz MA, Nicholson GC, Duncan EL, Major G, Horne A, Gilchrist N, Ralston SH. Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget\u2019s disease of bone. Ann Rheum Dis. 2024;83(4):529\u201336.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4412_CR46","doi-asserted-by":"publisher","first-page":"e9068","DOI":"10.1002\/ccr3.9068","volume":"12","author":"D Ma","year":"2024","unstructured":"Ma D, Xiao C, Zhao D, Li G, Cheng W, Deng X, He D, Liu K. Posterior scleritis following a single infusion of zoledronate for osteoporosis: A case report and literature review. Clin Case Rep. 2024;12(6):e9068.","journal-title":"Clin Case Rep"},{"issue":"1","key":"4412_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11657-021-00964-z","volume":"16","author":"X Jin","year":"2021","unstructured":"Jin X, Shou Z, Shao Y, Bian P. Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature. Arch Osteoporos. 2021;16(1):104.","journal-title":"Arch Osteoporos"},{"key":"4412_CR48","doi-asserted-by":"publisher","first-page":"2050313X2094430","DOI":"10.1177\/2050313X20944305","volume":"8","author":"K Anandasayanan","year":"2020","unstructured":"Anandasayanan K, Malaravan M, Suganthan N. Acute unilateral anterior uveitis following zoledronic acid infusion: A case report. SAGE Open Med Case Rep. 2020;8:2050313X20944305.","journal-title":"SAGE Open Med Case Rep"},{"issue":"1","key":"4412_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11657-025-01523-6","volume":"20","author":"A Liu","year":"2025","unstructured":"Liu A, Paulson C, Krauspe E, Perchik M, Desautels J, Crosby A. Orbital inflammation following zoledronic acid infusion. Arch Osteoporos. 2025;20(1):52.","journal-title":"Arch Osteoporos"},{"key":"4412_CR50","doi-asserted-by":"crossref","unstructured":"Chartrand NA, Lau CK, Parsons MT, Handlon JJ, Ronquillo YC, Hoopes PC, Moshirfar M. Ocular side effects of bisphosphonates: a review of literature. J Ocul Pharmacol Ther. 2023 Jan-Feb;39(1):3\u201316.","DOI":"10.1089\/jop.2022.0094"},{"issue":"9","key":"4412_CR51","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00198-023-06831-6","volume":"34","author":"S Karpuz","year":"2023","unstructured":"Karpuz S. Zoledronic acid-induced severe lymphopenia. Osteoporos Int. 2023;34(9):1653\u20135.","journal-title":"Osteoporos Int"},{"issue":"12","key":"4412_CR52","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00198-005-1986-1","volume":"16","author":"BA Barrera","year":"2005","unstructured":"Barrera BA, Wilton L, Harris S, Shakir SA. Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England. Osteoporos Int. 2005;16(12):1989\u201398.","journal-title":"Osteoporos Int"},{"issue":"1","key":"4412_CR53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/odi.13746","volume":"28","author":"C Van Poznak","year":"2022","unstructured":"Van Poznak C, Reynolds EL, Estilo CL, Hu M, Schneider BP, Hertz DL, Gersch C, Thibert J, Thomas D, Banerjee M, Rae JM, Hayes DF. Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer. Oral Dis. 2022;28(1):193\u2013201.","journal-title":"Oral Dis"},{"issue":"1","key":"4412_CR54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1248\/bpb.b16-00521","volume":"40","author":"K Shima","year":"2017","unstructured":"Shima K, Tsuchiya M, Oizumi T, Takano-Yamamoto T, Sugawara S, Endo Y. Inflammatory Effects of Nitrogen-Containing Bisphosphonates (N-BPs): Modulation by Non-N-BPs. Biol Pharm Bull. 2017;40(1):25\u201333.","journal-title":"Biol Pharm Bull"},{"key":"4412_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2025.11.012","volume":"242","author":"CC Chang","year":"2025","unstructured":"Chang CC, Sivakumar G, Huang MC, Chen YH, Wu SR, Lai YJ, Lai CH, Tu LH. Both single mutation and molecular conjugation on the mutant prevent calcitonin from forming amyloid fibrils. Biochimie. 2025;242:1\u20138.","journal-title":"Biochimie"},{"key":"4412_CR56","doi-asserted-by":"crossref","unstructured":"Xie J, Guo J, Kanwal Z, Wu M, Lv X, Ibrahim NA, Li P, Buabeid MA, Arafa EA, Sun Q. Calcitonin and bone physiology: in vitro, in vivo, and clinical investigations. Int J Endocrinol. 2020;2020:3236828.","DOI":"10.1155\/2020\/3236828"},{"issue":"11","key":"4412_CR57","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1021\/acs.jcim.4c00553","volume":"64","author":"F Huang","year":"2024","unstructured":"Huang F, Huang J, Yan J, Liu Y, Lian J, Sun Q, Ding F, Sun Y. Molecular Insights into the Effects of F16L and F19L Substitutions on the Conformation and Aggregation Dynamics of Human Calcitonin. J Chem Inf Model. 2024;64(11):4500\u201310.","journal-title":"J Chem Inf Model"},{"issue":"Pt 1","key":"4412_CR58","doi-asserted-by":"publisher","first-page":"142254","DOI":"10.1016\/j.ijbiomac.2025.142254","volume":"308","author":"VHG Phan","year":"2025","unstructured":"Phan VHG, Nguyen BT, Nguyen NY, Tran CD, Nguyen QD, Luu CH, Manivasagan P, Jang ES, Yang DC, Yang DU, Li Y, Conde J, Thambi T. Longan-inspired chitosan-pectin core-shell hydrogel beads for oral delivery of biodrugs to enhance osteoporosis therapy. Int J Biol Macromol. 2025;308(Pt 1):142254.","journal-title":"Int J Biol Macromol"},{"key":"4412_CR59","doi-asserted-by":"crossref","unstructured":"Maatallah K, Rahmouni S, Miladi S, Rouached L, Ferjeni H, Fazaa A, Laatar A, Kaffel D, Hamdi W. Paget\u2019s disease of bone in Tunisia: a study of 69 patients. Indian J Endocrinol Metab. 2020 Sep-Oct;24(5):422\u20137.","DOI":"10.4103\/ijem.IJEM_239_20"},{"issue":"2","key":"4412_CR60","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5001\/omj.2016.28","volume":"31","author":"O Elshafie","year":"2016","unstructured":"Elshafie O, Alsaffi N, Hussain S, Woodhouse N. Paget\u2019s Disease in an Omani: Long-term Improvement Following a Single Injection of Zoledronic Acid. Oman Med J. 2016;31(2):146\u20139.","journal-title":"Oman Med J"},{"issue":"11","key":"4412_CR61","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.3390\/ijms26114990","volume":"26","author":"E Gkikopoulou","year":"2025","unstructured":"Gkikopoulou E, Syrigos CC, Mantogiannakou I, Petraki CE, Stathopoulou M, Dragolia M, Rinotas V, Ntafis V, Rauner M, Douni E. RANKL Drives Bone Metastasis in Mammary Cancer: Protective Effects of Anti-Resorptive Treatments. Int J Mol Sci. 2025;26(11):4990.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4412_CR62","first-page":"158","volume":"9","author":"V Kamalumpundi","year":"2023","unstructured":"Kamalumpundi V, Shams E, Torfah M, Correia ML. Amelioration of Paget Disease of Bone After Denosumab for Osteopenia. AACE Clin Case Rep. 2023;9(5):158\u201361.","journal-title":"AACE Clin Case Rep"},{"issue":"1","key":"4412_CR63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00223-025-01370-0","volume":"116","author":"SA Polyzos","year":"2025","unstructured":"Polyzos SA, Anastasilakis K, Cundy T, Kita M. Long-Term Denosumab Treatment in Adults with Juvenile Paget Disease. Calcif Tissue Int. 2025;116(1):60.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"4412_CR64","doi-asserted-by":"publisher","first-page":"luaf031","DOI":"10.1210\/jcemcr\/luaf031","volume":"3","author":"O Magvanjav","year":"2025","unstructured":"Magvanjav O, Bergwitz C. Treatment of Extraosseous Giant Cell Tumor of Bone and Calcitriol-Mediated Hypercalcemia with Denosumab in Paget Disease. JCEM Case Rep. 2025;3(4):luaf031.","journal-title":"JCEM Case Rep"},{"issue":"10","key":"4412_CR65","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00198-022-06443-6","volume":"33","author":"R Pal","year":"2022","unstructured":"Pal R, Bhadada SK. Comment on Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget\u2019s Disease of Bone. Osteoporos Int. 2022;33(10):2227\u20138.","journal-title":"Osteoporos Int"},{"issue":"4","key":"4412_CR66","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1172\/JCI133473","volume":"130","author":"JY Li","year":"2020","unstructured":"Li JY, Yu M, Pal S, Tyagi AM, Dar H, Adams J, Weitzmann MN, Jones RM, Pacifici R. Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota. J Clin Invest. 2020;130(4):1767\u201381.","journal-title":"J Clin Invest"},{"issue":"3","key":"4412_CR67","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/joim.12805","volume":"284","author":"AG Nilsson","year":"2018","unstructured":"Nilsson AG, Sundh D, B\u00e4ckhed F, Lorentzon M. Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial. J Intern Med. 2018;284(3):307\u201317.","journal-title":"J Intern Med"},{"issue":"3","key":"4412_CR68","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1016\/S2665-9913(19)30068-2","volume":"1","author":"PA Jansson","year":"2019","unstructured":"Jansson PA, Curiac D, Lazou Ahr\u00e9n I, Hansson F, Martinsson Niskanen T, Sj\u00f6gren K, Ohlsson C. Probiotic treatment using a mix of three Lactobacillusstrains for lumbar spine bone loss in postmenopausal women: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Rheumatol. 2019;1(3):e154\u201362.","journal-title":"Lancet Rheumatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04412-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04412-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04412-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:00:11Z","timestamp":1785816011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04412-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4412"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04412-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"263"}}